Finally, to rule out potential confounding effects of adoptive transfer, and to determine the effect on in vivo antitumor effects of CD8+ T cells, we utilized the well-characterized subcutaneous model of B16-F10 melanoma cells that has been extensively utilized to determine the effects of immune checkpoint blockers, as in Methods (24). The gene discussed is CD8A; the disease is melanoma.